Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes. Keywords : ['potential screening marker', 'vascular disease', 'diabetes', 'cyclophilina'] Author : S Ramachandran 3
Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes. Keywords : ['potential screening marker', 'vascular disease', 'diabetes', 'cyclophilina'] Author : S Ramachandran 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Keywords : ['oral antidiabetic drug current evidence', 'new drug', 'regulatory requirement', 'cardiovascular risk'] Author : GK Panicker 3
